Introduction
============

Cardiac arrest is a crucial medical emergency. The annual incidence was \~132/100,000 in the US population.[@b1-oaem-8-067] Although we currently have new technology to support postcardiac arrest patients, the survival rate to hospital discharge is quite low in the range of 0.5%--8.5%.[@b2-oaem-8-067] Previous studies have reported that factors that influenced mortality included patient status, shockable rhythm, witnessed cardiac arrest, bystander cardiopulmonary resuscitation (CPR), and also targeted temperature management (TTM).[@b3-oaem-8-067]--[@b5-oaem-8-067]

TTM was introduced as part of the postcardiac arrest care bundle for out-of-hospital cardiac arrest (OHCA) patients, because this measurement potentially improved Cerebral Performance Category (CPC) scale score and survival rates to hospital discharge.[@b6-oaem-8-067],[@b7-oaem-8-067] From our previous report, the survival rate of OHCA patients before the implementation of TTM was only 8.2%.[@b8-oaem-8-067]

Songklanagarind Hospital is the biggest tertiary university hospital in Southern Thailand. Our hospital implemented TTM for postcardiac arrest care in 2012. Although the major benefits of TTM are in cardiac arrest patients from cardiac origins, our hospital protocol intentionally introduced TTM in every OHCA patient after obtaining return of spontaneous circulation (ROSC). However, the clinical and neurological outcomes remain unclear. Therefore, we aimed to evaluate the clinical and neurological outcomes of our treatment protocol and identify factors influencing survival to hospital discharge in OHCA patients within our institute.

Patients and methods
====================

Study design
------------

This study was a secondary analysis from the Medical Intensive Care Unit (MICU)-TTM registry between November 2012 and November 2015. The MICU-TTM registry is a local database of the TTM protocol in our MICU of every adult OHCA patient who obtained ROSC and was admitted to the MICU for postcardiac arrest care. All demographic data, medical history, and CPR details along with clinical and neurological outcomes were recorded in the registry. The protocol of this study was approved by the ethics committee of the Faculty of Medicine, Prince of Songkla University (EC number: 59-085-14-1). A waiver of consent was approved for inclusion in this study, and the investigators signed a confidentially agreement.

TTM protocol
------------

The postcardiac arrest committee of Songklanagarind Hospital launched a TTM protocol in October 2012. The eligible criteria for TTM in OHCA patients are adult patients (age ≥18 years) who obtained ROSC with unconsciousness (a score of \<8 on the Glasgow Coma Scale \[on which scores range from 3 to 15, with lower scores representing reduced levels of consciousness\]), any initial electrocardiographic rhythms, and no contraindication for hypothermia.[@b9-oaem-8-067]

After informed consent was received from a patient's next of kin, 1 L of cold saline was intravenously infused. Subsequently, a surface cooling device was applied to rapidly induce the body temperature to 33°C and maintained the target temperature during the maintenance phase for 24 hours. The Arctic Sun® machine (Medivance Inc, Louisville, CO, USA) is the standard surface cooling machine in our unit. Core temperatures were measured by an esophageal temperature probe. Patients were then rewarmed to 37°C with a rate of 0.25°C/h and maintained at this temperature for further 48 hours. Cardiovascular, respiratory, and electroencephalogram (EEG) monitoring and serial blood tests were strictly performed according to our unit protocol. Other medical managements (ie, primary coronary intervention, infusion of intravenous thrombolytic agents, and renal replacement therapy) depended on the decision of the intensivists in charge.

Data collection
---------------

Demographic data included sex, age, medical history, characteristics of the cardiac arrest, location of the cardiac arrest, bystander-witnessed cardiac arrest, bystander CPR, first monitored electrocardiographic rhythm, time from cardiac arrest to event, CPR time, number of defibrillations, adrenaline dose, and causes of cardiac arrest. Data on clinical characteristics of the patients on admission were first measured body temperature, Glasgow Coma Scale score, presence of corneal reflex and papillary reflex, serum pH and lactate, presence of circulatory shock defined as a systolic blood pressure of ≤ 90 mmHg for \>30 minutes or end-organ hypoperfusion (ie, cool extremities, a urine output of \<30 mL/h, and a heart rate of \<60 beats per minute), ST segment elevation myocardial infarction, and the Acute Physiologic Assessment and Chronic Health Evaluation II (APACHE II) score.

The therapeutic hypothermia process included time from ROSC until TTM was initiated, phases of TTM, and the patient's body temperature at 24 hours, 48 hours, and 72 hours. We also recorded serious TTM complications and in-hospital complications. Procedures performed during admission were also recorded.

Outcomes
--------

The primary outcomes evaluated were mortality and neurological outcomes after TTM. A mortality outcome was classified as "survivor" if the patient was discharged alive from the hospital and "nonsurvivor" if the patient died in the hospital. Neurological outcomes were defined according to the CPC scale[@b10-oaem-8-067],[@b11-oaem-8-067] and the modified Rankin Scale.[@b12-oaem-8-067],[@b13-oaem-8-067] Poor neurological outcomes were classified if the CPC scale score at discharge was \>2. The CPC scores ranged from 1 to 5, with 1 representing good cerebral performance or minor disability, 2 representing moderate cerebral disability (function is sufficient for independent activity of daily life), 3 representing severe cerebral disability, 4 representing coma or vegetative state, and 5 representing brain death. Scores on the modified Rankin Scale ranged from 0 to 6, with 0 representing no symptoms, 1 representing no clinically significant disability despite some symptoms, 2 representing slight disability (patient is able to look after their own affairs without assistance), 3 representing moderate disability (patient requires some help but is able to walk unassisted), 4 representing moderately severe disability (patient is unable to attend to their own bodily needs), 5 representing severe disability (patient is bedridden), and 6 representing death.

Another objective was to identify factors influencing poor clinical and neurological outcomes after TTM.

Statistical analysis
--------------------

Categorical data were demonstrated as percentages. Continuous data were shown as mean ± standard deviation, or median (with minimum and maximum, interquartile range), depending on the distribution of the data. The data were tested for normality using the Kolmogorov--Smirnov goodness-of-fit test. For the primary outcomes, the chi-square test or Fisher's exact test was performed for categorical data. Student's *t*-test or Mann--Whitney *U* test was selected for continuous variable analysis. Selected variables with *P*\<0.1 were introduced to a multiple logistic regression model. Odds ratios and their 95% confidence intervals were used to identify the significant independent influencing factors to mortality and poor neurological outcomes after TTM. Two-tailed values of *P*\<0.05 were deemed statistically significant. All statistical analyses were computed with the SPSS® statistical package version 16 (SPSS Inc., Chicago, IL, USA).

Results
=======

Patients
--------

A total of 23 OHCA patients were enrolled from November 2012 to November 2015 for TTM ([Figure 1](#f1-oaem-8-067){ref-type="fig"}). The mean age was 54.5 years. Almost all the patients were males and developed cardiac arrest at home with a witness, but only 17.4% were resuscitated by witnesses. The most frequent rhythm was ventricular fibrillation and cause of arrest was predominantly of cardiac origin. The mean CPR time was 21 minutes ([Table 1](#t1-oaem-8-067){ref-type="table"}).

In ROSC patients, the mean core temperature at the time of ICU admission was 36.8°C. Almost all of the patients were shocked, had metabolic acidosis, and were comatose. The mean APACHE II score was 21.

TTM process
-----------

The TTM process was performed initially at the MICU. The mean time from ROSC to the start of TTM was 4.39 hours. Patients were induced with cold saline, or cold gastric lavage. The temperature was managed with a surface cooling system (Arctic Sun®) in all patients. The durations of induction, maintenance, and rewarm phase were 3 hours, 24 hours, and 8 hours, respectively.

Complications of TTM occurred in only 13% of the patients. The most common complications were cardiac arrhythmias and hypotension. In-hospital complications occurred in 87% of the patients; the most common complication was ventilator-associated pneumonia. Coronary angiography and percutaneous coronary intervention were performed only in 21.7% and 13% of the patients, respectively. EEG was performed in the intensive care unit in 34.8% of the patients ([Table 2](#t2-oaem-8-067){ref-type="table"}).

Primary outcomes
----------------

Regarding the outcome of postcardiac arrest patients treated with TTM, survival until hospital discharge was 47.8%, but only 13% had a good neurological outcome (CPC 1--2). Most patients were in a vegetative state. The mortality rate was 52.2%. The most common cause of death was multiple organ failure ([Table 3](#t3-oaem-8-067){ref-type="table"}). In patients with shockable and nonshockable rhythms, the survivors were 73% and 27% (*P*=0.04 as per Fisher's exact test) and good neurological outcomes were 27% and 0% (*P*=0.9), respectively.

Secondary outcomes
------------------

Survival patients had shockable rhythms and low APACHE II scores compared with the nonsurvival patients.

In multivariate analysis, initial shockable rhythm was positively associated with survival at hospital discharge (odds ratio 10.1, 95% confidence interval 1.1--94.3, *P*=0.04). The group with poor neurological outcomes had a significantly higher APACHE II score than the group with good neurological outcomes (22.9±4.2 vs 16.0±3.6, *P*=0.01) ([Tables 4](#t4-oaem-8-067){ref-type="table"} and [5](#t5-oaem-8-067){ref-type="table"}).

Discussion
==========

The results of TTM projected in OHCA patients in our institute revealed that the survival rate until discharge was 47.8%, but only 13% obtained a good neurological outcome.

After two randomized controlled studies were reported,[@b6-oaem-8-067],[@b7-oaem-8-067] TTM was recommended in the international CPR guidelines.[@b4-oaem-8-067] TTM showed benefits in decreasing mortality and improving the neurological outcomes in comatose OHCA patients.

When compared with the pre-TTM era, the survival rate and neurological outcome (CPC 1--2) in our institute improved (8.2% vs 47.8% and 4.1% vs 13%, respectively),[@b8-oaem-8-067] but other sites had better survival rates (50%--52%) as well as better neurological outcomes (47%).[@b14-oaem-8-067] The first reason may be that we included nonshockable and shockable rhythm patients to perform TTM. Since shockable rhythm has a better prognosis than nonshockable rhythm,[@b15-oaem-8-067]--[@b18-oaem-8-067] one randomized clinical trial and one quasirandomized clinical trial restricted the inclusion criteria to only patients with shockable rhythm.[@b6-oaem-8-067],[@b7-oaem-8-067] Second, our patients spent a long time in cardiac arrest and had a low number of bystander CPRs when compared with other studies.[@b6-oaem-8-067],[@b7-oaem-8-067],[@b14-oaem-8-067] Third, although the leading cause of arrest was cardiac in origin, the rate of percutaneous coronary intervention in our institute was quite low. In a study of coronary angiography in postcardiac arrest patients with suspected cardiovascular cause, a coronary artery lesion was found in 96% of patients with ST elevation and in 58% of patients without ST elevation.[@b19-oaem-8-067] Some studies showed the benefits in early coronary angiography in patients with a presumed cardiac cause whether ST elevation or not.[@b15-oaem-8-067],[@b16-oaem-8-067] Finally, many patients had high core temperatures after 72 hours after the rewarming phase. Rebound fever was associated with mortality.[@b20-oaem-8-067] However, some studies did not show an association with rebound fever and neurological outcomes, or survival rate until discharge.[@b18-oaem-8-067],[@b19-oaem-8-067]

This study showed that TTM could be performed with minor complications in our center. However, a large number of patients had ventilator-associated pneumonia, which is similar to other TTM studies.[@b6-oaem-8-067],[@b7-oaem-8-067],[@b14-oaem-8-067] We also found that 30.4% of patients had status epilepticus after cardiac arrest in spite of the fact that continuous EEG monitoring was done in only 34.8% of the patients. Malignant EEG patterns are common in comatose postcardiac arrest patients.[@b21-oaem-8-067] The benefits from the treatment of electroencephalographic status epilepticus after CPR may come from an ongoing trail.[@b22-oaem-8-067]

Regarding the strength of the study, this study is the largest report of TTM among the tertiary hospitals in Thailand. The results of this TTM project are important to improve the process of care in our institute and in the country.

Our study had several limitations. First, it was a small retrospective study at a single center. Second, we did not perform long-term follow-up in the survival patients. Furthermore, the 3-year period of the study was quite short; hence, we had data from a small number of patients.

The results of this study suggest that we have to improve both the knowledge of people attempting bystander CPR and the referral system to minimize delay time to the hospitals. TTM should be conducted at the emergency department as quickly as possible, and controlling the temperature after rewarming is crucial since it is associated with survival outcomes.

Conclusion
==========

In this study, TTM in OHCA patients demonstrated better mortality benefits compared to pre-TTM implementation despite the poor neurological outcomes. Ventilator-associated pneumonia was the major complication of TTM. Nevertheless, TTM should be considered in OHCA patients, especially in shockable rhythms after obtaining ROSC.
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###### 

Baseline characteristics of patients treated with targeted temperature management

  Characteristics                                                      
  -------------------------------------------------------------------- -------------
  Age, mean ± SD (years)                                               54.48±18.18
  Male sex                                                             20 (87)
  Medical history                                                      
   Asthma or COPD                                                      5 (21.7)
   Diabetes mellitus                                                   4 (17.4)
   Arterial hypertension                                               5 (21.7)
   Coronary artery disease                                             5 (21.7)
   Previous TIA or stroke                                              1 (4.3)
   Chronic kidney disease                                              2 (8.7)
   Others                                                              4 (17.4)
  Characteristics of cardiac arrest                                    
   Location of cardiac arrest                                          
    Home                                                               16 (69.6)
    Public place                                                       7 (30.4)
    Bystander-witnessed cardiac arrest                                 21 (91.3)
    Bystander CPR                                                      4 (17.4)
   First monitored ECG rhythm                                          
    Shockable rhythm                                                   11 (47.8)
    Ventricular fibrillation                                           11 (47.8)
    Nonshockable rhythm                                                12 (52.2)
    Pulseless electrical activity                                      3 (13)
    Asystole                                                           9 (39.1)
   Time from cardiac arrest to event (minutes)                         
    Start of basic life support, mean ± SD                             17.7± 1.4
    Start of advanced life support, mean ± SD                          18.3±1.3
    Return of spontaneous circulation, mean ± SD                       40.3±2.1
   CPR time, mean ± SD (minutes)                                       21.0±1.2
   Defibrillations                                                     16 (69.6)
   Adrenaline dose, mean ± SD (mg)                                     6.7±3.7
   Causes of cardiac arrest                                            
    Cardiac causes                                                     12 (52.2)
    Trauma                                                             2 (8.7)
    Respiratory failure                                                7 (30.4)
    Metabolic causes                                                   1 (4.3)
    Unidentified causes                                                1 (4.3)
  Clinical characteristics during admission                            
   First measured body temperature, mean ± SD (°C)                     36.8±0.71
   GCS score,[a](#tfn2-oaem-8-067){ref-type="table-fn"} median (IQR)   3 (3--4)
   Corneal reflex present                                              13 (56.5)
   Pupillary reflex present                                            18 (78.3)
   Serum pH, mean ± SD                                                 7.1 ±0.02
   Serum lactate, mean ± SD (mmol/L)                                   9.2±6.4
   Circulatory shock[b](#tfn3-oaem-8-067){ref-type="table-fn"}         21 (91.3)
   ST segment elevation myocardial infarction                          6 (26.1)
   APACHE II score, mean ± SD                                          22.0±4.8

**Notes:** Data are presented as number (%) unless otherwise specified.

Scores on the GCS range from 3 to 15, with lower scores indicating reduced levels of consciousness.

Circulatory shock was defined as a systolic blood pressure of \<90 mmHg for \>30 minutes or end-organ hypoperfusion (ie, cool extremities, a urine output \<30 mL/h and a heart rate \<60 beats per minute).

**Abbreviations:** APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation II; COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; ECG, electrocardiography; GCS, Glasgow Coma Scale; IQR, interquartile range; SD, standard deviation; TIA, transient ischemic attack.

###### 

Therapeutic hypothermia process

  Variables                                  
  ------------------------------------------ -------------
  Time from ROSC to TTM, mean ± SD (hours)   4.39± 1.23
  Induction time, median (IQR) (hours)       3 (3--4)
  Maintenance time, median (IQR) (hours)     24 (24--26)
  Rewarming time, median (IQR) (hours)       8 (7--10)
  BT at 24 hours, mean ± SD (°C)             37.0±0.47
  BT at 48 hours, mean ± SD (°C)             37.5±0.76
  BT at 72 hours, mean ± SD (°C)             37.7±0.69
  Serious TTM complications, n (%)           3 (13)
   Arrhythmias                               1 (4.3)
   Circulatory instability                   2 (8.7)
  In-hospital complications, n (%)           20 (87)
   VAP                                       10 (43.5)
   CA-UTI                                    3 (13)
   AKI                                       5 (21.7)
   Status epilepticus                        7 (30.4)
   Others                                    1 (4.3)
  Procedure, n (%)                           
   CAG                                       5 (21.7)
   PCI                                       3 (13.0)
   CT brain                                  10 (43.3)
   EEG                                       8 (34.8)

**Note:** Data are presented as number (%) unless otherwise specified.

**Abbreviations:** AKI, acute kidney injury; BT, body temperature; CA-UTI, catheter-associated urinary tract infection; CAG, coronary angiography; CT, computed tomography; EEG, electroencephalogram; IQR, interquartile range; PCI, percutaneous coronary intervention; ROSC, return of spontaneous circulation; SD, standard deviation; TTM, targeted temperature management; VAP, ventilator-associated pneumonia.

###### 

Outcomes

  Variables                                                               
  ----------------------------------------------------------------------- -------------
  Primary outcomes                                                        
   Survival until discharge                                               11 (47.8)
   CPC score at discharge day[a](#tfn8-oaem-8-067){ref-type="table-fn"}   
    CPC of 1                                                              2 (8.7)
    CPC of 2                                                              1 (4.3)
    CPC of 3                                                              0
    CPC of 4                                                              8 (34.8)
    CPC of 5                                                              12 (52.2)
   mRS at discharge day[b](#tfn9-oaem-8-067){ref-type="table-fn"}         
    mRS of 0                                                              0
    mRS of 1                                                              2 (8.7)
    mRS of 2                                                              0
    mRS of 3                                                              1 (4.3)
    mRS of 4                                                              8 (34.8)
    mRS of 5                                                              0
    mRS of 6                                                              12 (52.2)
  Secondary outcomes                                                      
   Mechanical ventilation day, mean ± SD (days)                           16.44± 1.56
   ICU LOS, mean ± SD (days)                                              6.53±4.69
   Hospital stay mean ± SD (days)                                         18.88±1.85
   Death in hospital                                                      12 (52.2)
   Septic shock                                                           3 (13)
   Acute myocardial infarction                                            3 (13)
   Hypoxic--ischemic encephalopathy                                       2 (8.7)
   Multiple organ failure                                                 4 (17.4)

**Notes:** Data are presented as number (%) unless otherwise specified.

The CPC scale ranges from 1 to 5, with 1 representing good cerebral performance or minor disability, 2 representing moderate cerebral disability (function is sufficient for independent activity daily life), 3 representing severe cerebral disability, 4 representing coma or vegetative state, and 5 representing brain death.

The mRS ranges from 0 to 6, with 0 representing no symptoms, 1 representing no clinically significant disability despite some symptoms, 2 representing slight disability (patient is able to look after their own affairs without assistance), 3 representing moderate disability (patient requires some help but is able to walk unassisted), 4 representing moderately severe disability (patient is unable to attend to own bodily needs), 5 representing severe disability (patient is bedridden), and 6 representing death.

**Abbreviations:** CPC, Cerebral Performance Category; ICU LOS, intensive care unit length of stay; mRS, modified Rankin Scale; SD, standard deviation.

###### 

Comparison of survivor and death groups until discharge

  Variables   Survivor (n=11)   Death (n=12)   *P*-value
  ----------- ----------------- -------------- -----------
  Shockable   8 (72.7)          3 (25)         0.03
  Shock       9 (81.8)          12 (100)       0.21
  STEMI       5 (45.4)          1 (8.3)        0.06
  APACHE II   20.09±3.91        23.83±4.89     0.05

**Note:** Data are presented as number (%) unless otherwise specified.

**Abbreviations:** APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation II; STEMI, ST-elevation myocardial infarction.

###### 

Factors associated with neurological outcomes

  Variables                          Good (n=3)   Poor (n=20)   *P*-value
  ---------------------------------- ------------ ------------- -----------
  APACHE II score                    16.0±3.60    22.9±4.26     0.01
  Initial GCS-M                      1.66± 1.15   1.11 ±0.44    0.11
  Time from cardiac arrest to ACLS   10.0±0.00    19.55±13.77   0.25
  pH                                 7.23±0.07    7.09±0.20     0.25
  Mechanical ventilation day         6.33±4.93    17.96±16.22   0.23
  Shockable, n (%)                   3 (100)      8 (40)        0.09
  STEMI, n (%)                       2 (66.67)    4 (20)        0.15

**Note:** Data presented mean ± SD unless otherwise specified.

**Abbreviations:** ACLS, advanced cardiac life support; APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation II; GCS, Glasgow Coma Scale; GCS-M, GCS-motor; SD, standard deviation; STEMI, ST elevation myocardial infarction.
